Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression. Learn more here:

61,862 Aufrufe • vor 1 Jahr •via X (Twitter)

10 Kommentare

Profilbild von Simon P
Simon Pvor 1 Jahr

This is such encouraging news for the T1D community. It's great to see progress in this area, and the work being done is very promising. I hope this leads to even more breakthroughs.

Profilbild von Celt Naturals
Celt Naturalsvor 1 Jahr

Cold and Flu season getting you down? Immuno-Care can help your immune system work at peak performance. Our Health Canada approved natural health supplement is the best on the market and made in Canada. 7 key ingredients all specially coated to bypass harsh stomach acids.

Profilbild von john callinan
john callinanvor 1 Jahr

The last piece of the puzzle is becoming a reality. Thank you BT1D.

Profilbild von Mary Singh
Mary Singhvor 1 Jahr

Great news, great work BT1D. 👍💙

Profilbild von Jim Banting
Jim Bantingvor 1 Jahr

Maybe one day closer to extinguishing the Flame of Hope.

Profilbild von Namita
Namitavor 1 Jahr

What are the next steps? How far is this from becoming a cure for T1D?

Profilbild von Don Goldstein
Don Goldsteinvor 1 Jahr

This is huge!

Profilbild von Sahas Mehra
Sahas Mehravor 1 Jahr

Congratulations! Can anyone please share a link to the paper? Trying to find it.

Profilbild von Karen B
Karen Bvor 1 Jahr

@1derfultype This is absolutely fantastic news.

Profilbild von mehmetali KUTLU
mehmetali KUTLUvor 1 Jahr

How old did you use it?

Ähnliche Videos

Today, more than 170 delegates from all 50 states and five countries were in Washington for the 2025 Breakthrough Type 1 Diabetes Children’s Congress. I was proud to chair a Senate Appropriations Committee hearing to welcome the delegates and focus on the importance of federal investment in Type 1 diabetes research. Senator Jeanne Shaheen and I — the founding co-chairs of the bipartisan Senate Diabetes Caucus — introduced legislation this week to reauthorize the Special Diabetes Program, a federal initiative that provides $160 million annually for Type 1 diabetes research and prevention. Thanks to this program and the tireless advocacy of Breakthrough T1D and its Children’s Congress Delegates, we are seeing life changing breakthroughs in the fight against this terrible disease. Some of these developments include the now widely used continuous glucose monitors, the first FDA-approved artificial pancreas, and a groundbreaking clinical trial in which 10 of the 12 participants no longer need insulin to manage their diabetes because of a stem cell-based therapy. Since the founding of the Senate Diabetes Caucus in 1997, federal funding for diabetes research has increased from $319 million to more than $2.3 billion annually. I want to thank our outstanding witnesses for today’s hearing: Ruby Whitmore of Old Town, Maine, Rachel White of North Hampton, New Hampshire, Katie Bone of Bernalillo, New Mexico, and Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Their passionate testimony highlighted both the daily realities of living with type 1 diabetes and the vital role of continued federal research through agencies like the NIDDK. Finding a cure for Type 1 diabetes remains our ultimate goal and has been one of my highest priorities since the very beginning of my Senate service. With continued advocacy, bipartisan support, and strong federal investment, I am confident that day will come.

Sen. Susan Collins

12,348 Aufrufe • vor 1 Jahr